Natera EBIT 2014-2023 | NTRA
Natera annual and quarterly EBIT history from 2014 to 2023. EBIT can be defined as earnings before interest and taxes.
- Natera EBIT for the quarter ending December 31, 2023 was $-0.085B, a 40.37% decline year-over-year.
- Natera EBIT for the twelve months ending December 31, 2023 was $-0.446B, a 17.52% decline year-over-year.
- Natera 2023 annual EBIT was $-0.446B, a 17.52% decline from 2022.
- Natera 2022 annual EBIT was $-0.541B, a 15.56% increase from 2021.
- Natera 2021 annual EBIT was $-0.468B, a 116.47% increase from 2020.
| Natera Annual EBIT (Millions of US $) |
|
|---|---|
| 2023 | $-446 |
| 2022 | $-541 |
| 2021 | $-468 |
| 2020 | $-216 |
| 2019 | $-116 |
| 2018 | $-115 |
| 2017 | $-135 |
| 2016 | $-101 |
| 2015 | $-60 |
| 2014 | $1 |
| 2013 | $-25 |
| Natera Quarterly EBIT (Millions of US $) |
|
|---|---|
| 2023-12-31 | $-85 |
| 2023-09-30 | $-111 |
| 2023-06-30 | $-112 |
| 2023-03-31 | $-138 |
| 2022-12-31 | $-142 |
| 2022-09-30 | $-119 |
| 2022-06-30 | $-143 |
| 2022-03-31 | $-137 |
| 2021-12-31 | $-140 |
| 2021-09-30 | $-150 |
| 2021-06-30 | $-115 |
| 2021-03-31 | $-63 |
| 2020-12-31 | $-74 |
| 2020-09-30 | $-56 |
| 2020-06-30 | $-52 |
| 2020-03-31 | $-35 |
| 2019-12-31 | $-35 |
| 2019-09-30 | $-21 |
| 2019-06-30 | $-29 |
| 2019-03-31 | $-32 |
| 2018-12-31 | $-30 |
| 2018-09-30 | $-27 |
| 2018-06-30 | $-27 |
| 2018-03-31 | $-31 |
| 2017-12-31 | $-47 |
| 2017-09-30 | $-26 |
| 2017-06-30 | $-28 |
| 2017-03-31 | $-35 |
| 2016-12-31 | $-42 |
| 2016-09-30 | $-27 |
| 2016-06-30 | $-23 |
| 2016-03-31 | $-10 |
| 2015-12-31 | $-17 |
| 2015-09-30 | $-21 |
| 2015-06-30 | $-15 |
| 2015-03-31 | $-6 |
| 2014-12-31 | |
| 2014-09-30 | $5 |
| 2014-06-30 | $-1 |
| 2013-12-31 | |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $11.509B | $1.083B |
| Natera, Inc. offers genetic testing and diagnostics with proprietary bioinformatics and molecular technology. Natera, Inc. is headquartered in San Carlos, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $121.982B | 15.31 |
| Cencora (COR) | United States | $45.721B | 17.82 |
| ICON (ICLR) | Ireland | $24.881B | 23.49 |
| DiDi Global (DIDIY) | China | $23.865B | 0.00 |
| Avantor (AVTR) | United States | $16.588B | 24.42 |
| Viatris (VTRS) | United States | $13.847B | 3.98 |
| CochLear (CHEOY) | Australia | $13.505B | 0.00 |
| Revvity (RVTY) | United States | $12.674B | 22.21 |
| Medpace Holdings (MEDP) | United States | $12.327B | 40.56 |
| Charles River Laboratories (CRL) | United States | $11.986B | 21.85 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $11.385B | 0.00 |
| Solventum (SOLV) | United States | $11.239B | 0.00 |
| Sonic Healthcare (SKHHY) | Australia | $8.205B | 0.00 |
| HealthEquity (HQY) | United States | $6.843B | 51.12 |
| Organon (OGN) | United States | $4.843B | 4.66 |
| Bausch + Lomb (BLCO) | Canada | $4.828B | 19.35 |
| Doximity (DOCS) | United States | $4.479B | 33.35 |
| PACS (PACS) | United States | $3.736B | 0.00 |
| Sotera Health (SHC) | United States | $3.190B | 15.65 |
| Surgery Partners (SGRY) | United States | $3.131B | 28.98 |
| Progyny (PGNY) | United States | $3.103B | 52.08 |
| GoodRx Holdings (GDRX) | United States | $2.753B | 139.40 |
| Life Times (LTH) | United States | $2.557B | 27.08 |
| Premier (PINC) | United States | $2.523B | 9.24 |
| AMN Healthcare Services Inc (AMN) | United States | $2.270B | 7.34 |
| Teladoc Health (TDOC) | United States | $2.172B | 0.00 |
| Agilon Health (AGL) | United States | $2.039B | 0.00 |
| BrightSpring Health Services (BTSG) | United States | $1.825B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.390B | 0.00 | |
| Agiliti (AGTI) | United States | $1.374B | 22.44 |
| NovoCure (NVCR) | Jersey | $1.371B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.995B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.757B | 7.83 |
| Embecta (EMBC) | United States | $0.583B | 3.85 |
| GeneDx Holdings (WGS) | United States | $0.545B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.527B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.525B | 0.00 |
| Auna S.A (AUNA) | Luxembourg | $0.517B | 0.00 |
| Enhabit (EHAB) | United States | $0.511B | 46.27 |
| LifeMD (LFMD) | United States | $0.476B | 0.00 |
| CareDx (CDNA) | United States | $0.475B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.448B | 0.00 |
| MultiPlan (MPLN) | United States | $0.414B | 0.00 |
| Beauty Health (SKIN) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.353B | 56.50 |
| Sera Prognostics (SERA) | United States | $0.338B | 0.00 |
| ModivCare (MODV) | United States | $0.317B | 4.20 |
| Sharecare (SHCR) | United States | $0.263B | 0.00 |
| Ascend Wellness Holdings (AAWH) | United States | $0.260B | 0.00 |
| Biodesix (BDSX) | United States | $0.143B | 0.00 |
| So-Young (SY) | China | $0.127B | 42.67 |
| Oncology Institute (TOI) | United States | $0.083B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.071B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.053B | 0.00 |
| NeueHealth (NEUE) | United States | $0.051B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.037B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.035B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.030B | 0.00 |
| Nutex Health (NUTX) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| DermTech (DMTK) | United States | $0.021B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.014B | 0.00 |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.011B | 0.00 | |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.007B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.006B | 0.00 |
| OpGen (OPGN) | United States | $0.005B | 0.00 |
| Assure Holdings (IONM) | United States | $0.003B | 0.00 |
| ISpecimen (ISPC) | United States | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |